Live Quote · NASDAQMGXHealthcare· Biotechnology

Metagenomi, Inc. Common Stock

$0.56▼ 7.95%($-0.05)
MKT CAP $21.36MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
75
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MGX research report →

Analyst Price Target
$14.50+2466.4% vs. today

Range $7 – $22

Analyst RatingBuy
4 Buy1 Hold0 Sell

Price Chart

-62.58% · this period
$1.82$1.19$0.56Nov 20May 26Nov 20
52-Week Range0% of range
Low
$0.56
Current
$0.56
High
$1.87